======= RPL7A ======= == Gene Information == * **Official Symbol**: RPL7A * **Official Name**: ribosomal protein L7a * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6130|6130]] * **UniProt**: [[https://www.uniprot.org/uniprot/P62424|P62424]] * **Interactions**: [[https://thebiogrid.org/search.php?search=RPL7A&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RPL7A|Open PubMed]] * **OMIM**: [[https://omim.org/entry/185640|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |Ribosomal L7Ae| |maturation of LSU-rRNA| |polysomal ribosome| |cytosolic large ribosomal subunit| |ribosomal large subunit biogenesis| |SRP-dependent cotranslational protein targeting to membrane| |cotranslational protein targeting to membrane| |protein targeting to ER| |establishment of protein localization to endoplasmic reticulum| |viral transcription| |nuclear-transcribed mRNA catabolic process, nonsense-mediated decay| |viral gene expression| |protein localization to endoplasmic reticulum| |translational initiation| |protein targeting to membrane| |structural constituent of ribosome| |nuclear-transcribed mRNA catabolic process| |rRNA processing| |mRNA catabolic process| |rRNA metabolic process| |RNA catabolic process| |establishment of protein localization to membrane| |ribosome biogenesis| |cadherin binding| |protein targeting| |nucleobase-containing compound catabolic process| |translation| |ncRNA processing| |peptide biosynthetic process| |focal adhesion| |establishment of protein localization to organelle| |heterocycle catabolic process| |cellular nitrogen compound catabolic process| |aromatic compound catabolic process| |ribonucleoprotein complex biogenesis| |ncRNA metabolic process| |protein localization to membrane| |organic cyclic compound catabolic process| |amide biosynthetic process| |peptide metabolic process| |mRNA metabolic process| |viral process| |protein localization to organelle| |symbiotic process| |cellular amide metabolic process| |interspecies interaction between organisms| |nucleolus| |RNA processing| |cellular macromolecule catabolic process| |intracellular protein transport| |macromolecule catabolic process| |RNA binding| |organonitrogen compound biosynthetic process| |protein transport| |intracellular transport| |peptide transport| |amide transport| |cellular protein localization| |cellular macromolecule localization| |establishment of protein localization| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |macromolecule biosynthetic process| |organic substance catabolic process| |cellular catabolic process| |establishment of localization in cell| |nitrogen compound transport| |membrane| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp108|Vinblastine 0.2μM R03 exp108]]|-1.81| |[[:results:exp176|Apcin 50 to 100μM on day4 R04 exp176]]|1.72| |[[:results:exp351|Dexamethasone 0.006μM R07 exp351]]|1.72| |[[:results:exp160|Ribavirin 10 to 15μM on day4 R04 exp160]]|1.76| |[[:results:exp38|Wortmannin 5μM R00 exp38]]|1.76| |[[:results:exp112|S-DABN 8μM R03 exp112]]|1.84| |[[:results:exp27|Pimelic-diphenylamide-106 0.5μM R00 exp27]]|1.91| |[[:results:exp330|5-Azacytidine 2μM R07 exp330]]|1.97| |[[:results:exp10|CCCP 0.1μM R00 exp10]]|1.97| |[[:results:exp47|Lapatinib 5μM R01 exp47]]|1.97| |[[:results:exp16|DABN 2μM R00 exp16]]|2.11| |[[:results:exp417|Tubastatin-A 2.5μM R07 exp417]]|2.19| |[[:results:exp379|MSC2530818 10μM R07 exp379]]|2.23| |[[:results:exp41|BI-2536 0.001μM R01 exp41]]|2.28| |[[:results:exp5|Alpha-Amanitin 0.5μM R00 exp5]]|2.37| ^Gene^Correlation^ |[[:human genes:g:golga6l1|GOLGA6L1]]|0.514| |[[:human genes:p:pola2|POLA2]]|0.485| |[[:human genes:n:nol12|NOL12]]|0.439| |[[:human genes:v:vasn|VASN]]|0.434| |[[:human genes:n:nup133|NUP133]]|0.425| |[[:human genes:r:rrm2|RRM2]]|0.425| |[[:human genes:a:apobec3a|APOBEC3A]]|0.421| |[[:human genes:o:ogfr|OGFR]]|0.414| |[[:human genes:x:xylt2|XYLT2]]|0.413| |[[:human genes:r:rpl10a|RPL10A]]|0.409| |[[:human genes:r:rps19|RPS19]]|0.407| |[[:human genes:r:rps15|RPS15]]|0.405| |[[:human genes:s:slamf1|SLAMF1]]|0.404| |[[:human genes:o:orc1|ORC1]]|0.402| |[[:human genes:r:rpl32|RPL32]]|0.4| Global Fraction of Cell Lines Where Essential: 728/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|28/28| |blood|28/28| |bone|25/26| |breast|33/33| |central nervous system|56/56| |cervix|4/4| |colorectal|17/17| |esophagus|12/13| |fibroblast|1/1| |gastric|16/16| |kidney|20/21| |liver|20/20| |lung|73/75| |lymphocyte|16/16| |ovary|25/26| |pancreas|24/24| |peripheral nervous system|16/16| |plasma cell|15/15| |prostate|1/1| |skin|24/24| |soft tissue|9/9| |thyroid|2/2| |upper aerodigestive|22/22| |urinary tract|28/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 47 * **Expression level (log2 read counts)**: 9.83 {{:chemogenomics:nalm6 dist.png?nolink |}}